KCNE3, potassium voltage-gated channel subfamily E regulatory subunit 3, 10008
N. diseases: 48; N. variants: 5
Source: ALL
Disease | Type | Disease Class | Semantic Type | N. genes d | N. SNPs d | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
disease | Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | Disease or Syndrome | 23 | 0.100 | None | 0 | |||||||||
|
disease | Neoplasms; Endocrine System Diseases | Neoplastic Process | 156 | 9 | 0.100 | None | 0 | ||||||||
|
disease | Disease or Syndrome | 9 | 0.100 | None | 0 | ||||||||||
|
phenotype | Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | Disease or Syndrome | 559 | 111 | 0.020 | None | 1.000 | 2 | 2002 | 2016 | |||||
|
phenotype | Pathological Conditions, Signs and Symptoms; Nervous System Diseases | Sign or Symptom | 119 | 45 | 0.110 | None | 1.000 | 1 | 2012 | 2012 | |||||
|
phenotype | Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Otorhinolaryngologic Diseases | Disease or Syndrome | 103 | 14 | 0.010 | None | 1.000 | 1 | 2011 | 2011 | |||||
|
phenotype | Laboratory Procedure | 483 | 1142 | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||
|
phenotype | Laboratory Procedure | 563 | 1418 | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||
|
phenotype | Laboratory Procedure | 269 | 555 | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||
|
phenotype | Laboratory Procedure | 486 | 1243 | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||
|
phenotype | Pathological Conditions, Signs and Symptoms; Respiratory Tract Diseases; Nervous System Diseases | Finding | 13 | 1 | 0.100 | None | 0 | ||||||||
|
phenotype | Finding | 130 | 12 | 0.100 | None | 0 | |||||||||
|
phenotype | Cardiovascular Diseases | Finding | 23 | 0.100 | None | 0 | |||||||||
|
phenotype | Nutritional and Metabolic Diseases | Finding | 37 | 0.100 | None | 0 | |||||||||
|
phenotype | Finding | 18 | 3 | 0.100 | None | 0 | |||||||||
|
phenotype | Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | Finding | 28 | 0.100 | None | 0 | |||||||||
|
phenotype | Finding | 27 | 0.100 | None | 0 | ||||||||||
|
phenotype | Finding | 60 | 0.100 | None | 0 | ||||||||||
|
phenotype | Nutritional and Metabolic Diseases | Finding | 5 | 0.100 | None | 0 | |||||||||
|
phenotype | Pathological Conditions, Signs and Symptoms; Nervous System Diseases | Finding | 6 | 2 | 0.100 | None | 0 | ||||||||
|
phenotype | Finding | 7 | 0.100 | None | 0 | ||||||||||
|
group | Neoplasms | Neoplastic Process | 10161 | 1644 | 0.010 | None | 1.000 | 1 | 2016 | 2016 | |||||
|
group | Nervous System Diseases | Disease or Syndrome | 1515 | 85 | 0.010 | None | 1.000 | 1 | 2007 | 2007 |